Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ciprobay 200 mg/100 ml raztopina za infundiranje
bayer d.o.o. - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 200 mg / 100 ml - ciprofloksacin
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ciprofloksacin infomed fluids 2 mg/ml raztopina za infundiranje
infomed fluids srl - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ciprofloksacin infomed fluids 2 mg/ml raztopina za infundiranje
infomed fluids srl - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ciprofloksacin infomed fluids 2 mg/ml raztopina za infundiranjev
infomed fluids srl - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ciprofloksacin lek 400 mg/ 200 ml raztopina za infundiranje
lek d.d. - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 400 mg / 200 ml - ciprofloksacin
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ciprofloksacin infomed fluids 2 mg/ml raztopina za infundiranje
infomed fluids srl - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ciprobay 400 mg/200 ml raztopina za infundiranje
bayer d.o.o. - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 400 mg / 200 ml - ciprofloksacin
Uniunea Europeană -
slovenă -
EMA (European Medicines Agency)
competact
cheplapharm arzneimittel gmbh - pioglitazone, metformin hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.
Uniunea Europeană -
slovenă -
EMA (European Medicines Agency)
lyxumia
sanofi winthrop industrie - liksisenatid - diabetes mellitus, tip 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.
